Unknown

Dataset Information

0

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial.


ABSTRACT:

SUBMITTER: Humby F 

PROVIDER: S-EPMC7829614 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6344892 | biostudies-other
| S-EPMC3500530 | biostudies-literature
| S-EPMC9205785 | biostudies-literature
| S-EPMC6656352 | biostudies-literature
| S-EPMC3551223 | biostudies-literature
| S-EPMC5099201 | biostudies-literature
| S-EPMC10321123 | biostudies-literature
| S-EPMC7134526 | biostudies-literature
| S-EPMC5637911 | biostudies-literature
| S-EPMC6199530 | biostudies-literature